• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Coiled-coil domain-containing protein 84 (CCDC84)

ACP15569

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15569 Target NameCCDC84
Target SynonymsCCD84_HUMAN; Ccdc84; Coiled-coil domain-containing protein 84; DLNB14FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-332
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86UT8
Background Information
  • Uniprot Id

    Q86UT8

  • Target Species

    Human

  • Target Name

    CENATAC

  • Target Full Name

    Centrosomal AT-AC splicing factor

  • Target Function

    Negative regulator of centrosome duplication. Constrains centriole number by modulating the degradation of the centrosome-duplication-associated protein SASS6 in an acetylation-dependent manner. SIRT1 deacetylates CENATAC in G1 phase, allowing for SASS6 accumulation on the centrosome and subsequent procentriole assembly. The CENATAC acetylation level is restored in mitosis by NAT10, promoting SASS6 proteasome degradation by facilitating SASS6 binding to APC/C E3 ubiquitin-protein ligase complex/FZR1.

  • Target Subcellular Location

    Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.

  • Target Synonyms

    CCD84_HUMAN; Ccdc84; Coiled-coil domain-containing protein 84; DLNB14

Inquire Recombinant Human Coiled-coil domain-containing protein 84 (CCDC84) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification